Reimbursement
According to Dr. Bosserman, it is the oncology provider’s responsibility to make the patient’s voice heard among policymakers. This is how they ensure that patients achieve the best health outcomes.
Read More ›
Changes in oncology payment and reimbursement as well as delivery models were reviewed recently by an expert panel at the Cancer Center Business Summit (CCBS). Providers, payers, industry representatives, and thought leaders were on hand to share their thoughts and experiences. Read More ›
Changes in our economy and healthcare system (ie, the Affordable Care Act, accountable care organizations, evolving reimbursement models) have given birth to a new member of the healthcare team: the financial advocate. Read More ›
Regardless of which version you are considering, the International Classification of Diseases, Clinical Modification (ICD-CM) is a morbidity classification published by the United States for classifying diagnoses and reasons for visits in all healthcare settings. Read More ›
Cancer care and reimbursement are changing, according to the keynote address, “Ensuring Quality Care for Each Patient: How Legislative and Regulatory Changes May Impact Community Oncology,” at the 2014 Association of Community Cancer Centers’ 40th annual meeting. Read More ›